We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,050

China’s Patent Re-Examination Board says pharmaceutical salts not patentable over pure compounds
  • Greenberg Traurig LLP
  • China
  • August 14 2013

In July 2013, the Patent Re-Examination Board of China's State Intellectual Property Office invalidated the U.S. biotech company, Gilead Sciences'


Civil remedy plaintiff may seek against defendant and countermeasure defendant could use against plaintiff in patent infringement lawsuit in China
  • Beijing East IP Ltd
  • China
  • September 22 2013

China is becoming an arena of significant importance where companies are taking advantage of patent portfolios against competitors. According to


Beijing High Court issues Guidelines for Determining Patent Infringement
  • MMLC Group
  • China
  • November 11 2013

Beijing High People's Court issued Guidelines for Determining Patent Infringement on 4 September 2013, replacing the Opinions on Several Issues


Supreme Court decisions open up possibilities for amendment of Chinese patents
  • Bird & Bird
  • China
  • January 9 2013

In the past, China's State Intellectual Property Office (SIPO) and Patent Re-examination Board (PRB) adopted a relatively strict view on the scope of


Huawei, ZTE win another infringement lawsuit
  • Kangxin Partners PC
  • China, USA
  • September 18 2013

Chinese telecom equipment vendors Huawei Technologies Co Ltd and ZTE Corp have secured their second victory against a lawsuit claiming they infringed


Revise a patent claim in line with specifications and drawings? Possible
  • HaoLiWen
  • China
  • March 17 2014

According to the relevant judicial interpretations, in interpreting the content of a patent claim, the People's Court should rely on the description


China newsletter - summer 2013
  • Greenberg Traurig LLP
  • China, Macau
  • July 17 2013

For the purpose of fully implementing the spirit of the Eighteenth National Congress of the Communist Party of China and attracting more foreign


Life sciences: 2013 legal developments you need to know about
  • Mayer Brown LLP
  • China, European Union, France, USA
  • July 16 2013

This is a short guide outlining some of the key legal developments in the life sciences sector in 2013. The developments include the Supreme Court


Changing trends in patent protection for the pharma industry
  • Heskia - Hacmun Law Firm
  • China, India, Israel
  • June 6 2013

This April India's Supreme Court oversaw a high profile case involving Novartis' patent application for Glivec, a cancer-battling medication


The Supreme Court clarified patentee’s rights during the provisional protection period
  • Lifang & Partners
  • China
  • January 27 2014

If the allegedly infringing products were made, sold or imported during the provisional protection period from the publication date to the allowance